文献速递腹部技术与安全MR

脂肪性肝病对乙型肝炎相关肝细胞癌的影响:MRI表现与预后潜力

Impact of steatotic liver disease on hepatitis B-related hepatocellular carcinoma: MRI manifestation and prognostic potential.
PubMed 文献 · Br J Radiol · 2025-01-01

回顾性纳入441例HBV相关HCC患者(237例无SLD,204例合并SLD),比较临床与MRI特征并分析生存。合并SLD者总生存更好(P=.047),甲胎蛋白水平、肿瘤分级及微血管侵犯更低。多因素分析显示不邻近肝门或肝静脉汇合处、无廓清表现、包膜强化完整是合并SLD肿瘤的独立MRI特征。

要点

  • 合并SLD的HBV相关HCC患者总生存更好(P=.047)。
  • 合并SLD者甲胎蛋白水平、肿瘤分级及微血管侵犯更低。
  • 无廓清表现、包膜强化完整、不邻近肝门或肝静脉汇合处提示合并SLD可能。

核心结论

  • 对于HBV相关HCC,合并SLD似乎与更好的总生存相关,其临床和影像学特征不同,合并SLD者似乎侵袭性更低。

研究设计与样本

  • 回顾性纳入441例HBV相关HCC患者(平均年龄55.5岁±10.8,366例男性,237例无SLD,204例合并SLD),比较临床与MRI特征,采用Kaplan-Meier分析比较总生存和无复发生存,采用单因素和多因素分析识别合并与不合并SLD患者间的影像特征差异。

关键影像表现/征象

  • 合并SLD的HBV相关HCC患者总生存更好(P=.047)。
  • 合并SLD者甲胎蛋白水平(Z=7.82,P=.007)、肿瘤分级(χ2=6.567,P=.035)及微血管侵犯(χ2=6.252,P=.044)似乎更低。
  • 多因素分析显示,不邻近肝门或肝静脉汇合处(OR=1.624,P=.041)、无廓清表现(OR=2.047,P=.001)及包膜强化完整(OR=2.584,P=.003)是合并与不合并SLD肿瘤间显著不同的MRI表现。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: To investigate the impact of steatotic liver disease (SLD) on hepatitis B virus (HBV) related hepatocellular carcinoma (HCC) in clinical and MRI manifestations and prognostic potential.

METHODS: Four hundred and forty-one HBV-related HCC patients were retrospectively enrolled (mean age 55.5 years ±10.8, 366 males, 237 without and 204 with concurrent SLD). Kaplan-Meier analyses were performed to compare the overall survival (OS) and recurrence-free survival (RFS). Clinical and MRI characteristics were compared. Univariate and multivariate analyses were used to identify the different imaging features between patients with and without concurrent SLD.

RESULTS: Patients with concurrent SLD had a better OS (P = .047). Except for metabolism-related indicators, the level of alpha fetoprotein (Z = 7.82, P = .007), the grade of tumour lesion (χ2 = 6.567, P = .035) and microvascular invasion (χ2 = 6.252, P = .044) appeared to be lower in patients with SLD. According to the multivariate analysis, non-adjacent to porta hepatis or confluence of hepatic veins (odds ratio [OR] = 1.624, P = .041), absent washout appearance (OR = 2.047, P = .001) and intact enhancing capsule (OR = 2.584, P = .003) were significantly different MRI manifestations between tumours with and without SLD.

CONCLUSIONS: For HBV-related HCC, concurrent SLD tended to be associated with better OS. The clinical and radiological characteristics were different, which seemed to be less aggressive for those with concurrent SLD.

ADVANCES IN KNOWLEDGE: Concurrent SLD in HBV-related HCC patients may be associated with better overall survival, and it exhibits distinct clinical and radiological features, which seem to be less aggressive.

来源:Br J Radiol,查看原文。版权归原作者所有。

引用

  1. Zheng B, Xiao Y, Wu F, et al. Impact of steatotic liver disease on hepatitis B-related hepatocellular carcinoma: MRI manifestation and prognostic potential. Br J Radiol. 2025. PMID: 40444776. doi:10.1093/bjr/tqaf121

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。